SNY vs. BMY, BIIB, JNJ, MRK, ABBV, AZN, NVS, ABT, PFE, and VRTX
Should you be buying Sanofi stock or one of its competitors? The main competitors of Sanofi include Bristol-Myers Squibb (BMY), Biogen (BIIB), Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK), AbbVie (ABBV), AstraZeneca (AZN), Novartis (NVS), Abbott Laboratories (ABT), Pfizer (PFE), and Vertex Pharmaceuticals (VRTX). These companies are all part of the "medical" sector.
Bristol-Myers Squibb (NYSE:BMY) and Sanofi (NASDAQ:SNY) are both large-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, risk, dividends, valuation, analyst recommendations, community ranking and media sentiment.
Bristol-Myers Squibb pays an annual dividend of $2.40 per share and has a dividend yield of 6.0%. Sanofi pays an annual dividend of $1.48 per share and has a dividend yield of 3.1%. Bristol-Myers Squibb pays out -77.4% of its earnings in the form of a dividend. Sanofi pays out 74.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Bristol-Myers Squibb has increased its dividend for 16 consecutive years and Sanofi has increased its dividend for 2 consecutive years. Bristol-Myers Squibb is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.
Bristol-Myers Squibb received 1046 more outperform votes than Sanofi when rated by MarketBeat users. Likewise, 66.89% of users gave Bristol-Myers Squibb an outperform vote while only 53.23% of users gave Sanofi an outperform vote.
Bristol-Myers Squibb currently has a consensus target price of $60.00, suggesting a potential upside of 48.08%. Sanofi has a consensus target price of $55.00, suggesting a potential upside of 15.74%. Given Sanofi's higher probable upside, equities analysts plainly believe Bristol-Myers Squibb is more favorable than Sanofi.
Bristol-Myers Squibb has a beta of 0.45, meaning that its share price is 55% less volatile than the S&P 500. Comparatively, Sanofi has a beta of 0.61, meaning that its share price is 39% less volatile than the S&P 500.
Bristol-Myers Squibb has higher earnings, but lower revenue than Sanofi. Bristol-Myers Squibb is trading at a lower price-to-earnings ratio than Sanofi, indicating that it is currently the more affordable of the two stocks.
Sanofi has a net margin of 10.52% compared to Sanofi's net margin of -13.50%. Bristol-Myers Squibb's return on equity of 19.69% beat Sanofi's return on equity.
In the previous week, Bristol-Myers Squibb had 23 more articles in the media than Sanofi. MarketBeat recorded 36 mentions for Bristol-Myers Squibb and 13 mentions for Sanofi. Bristol-Myers Squibb's average media sentiment score of 0.71 beat Sanofi's score of 0.64 indicating that Sanofi is being referred to more favorably in the news media.
76.4% of Bristol-Myers Squibb shares are owned by institutional investors. Comparatively, 10.0% of Sanofi shares are owned by institutional investors. 0.1% of Bristol-Myers Squibb shares are owned by company insiders. Comparatively, 1.0% of Sanofi shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Summary
Sanofi beats Bristol-Myers Squibb on 11 of the 21 factors compared between the two stocks.
Get Sanofi News Delivered to You Automatically
Sign up to receive the latest news and ratings for SNY and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SNY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
